# Patent Law & Policy — New Papers Research (Step 1)

**Date**: 2026-02-14

---

## Bayh-Dole Act (1980)

### Hvide & Jones (2018)
- **Title**: "University Innovation and the Professor's Privilege"
- **Journal**: American Economic Review, Vol. 108, No. 7, pp. 1860-1898
- **URL**: https://doi.org/10.1257/aer.20160284
- **Policy change examined**: Bayh-Dole Act (Norway abolition of professor's privilege as natural experiment)
- **Research question**: Does a Bayh-Dole-style regime (university owns IP) increase or decrease university innovation?
- **Methodology**: Difference-in-differences using Norway's 2003 reform
- **Key finding**: A 50% decline in both entrepreneurship and patenting rates after moving to Bayh-Dole-like model. Quality also declined.
- **Relevance**: HIGH
- **Verification**: Confirmed on AEA website

### Henderson, Jaffe & Trajtenberg (1998)
- **Title**: "Universities as a Source of Commercial Technology: A Detailed Analysis of University Patenting, 1965-1988"
- **Journal**: Review of Economics and Statistics, Vol. 80, No. 1, pp. 119-127
- **URL**: https://doi.org/10.1162/003465398557276
- **Policy change examined**: Bayh-Dole Act
- **Research question**: Did the quality of university patents change after Bayh-Dole?
- **Methodology**: Citation analysis comparing university vs. random patents
- **Key finding**: Post-Bayh-Dole expansion accompanied by declining average patent quality; rate of important patents grew slower than overall patenting.
- **Relevance**: HIGH
- **Verification**: Confirmed on MIT Press

### Mowery, Nelson, Sampat & Ziedonis (2001)
- **Title**: "The Growth of Patenting and Licensing by U.S. Universities: An Assessment of the Effects of the Bayh-Dole Act of 1980"
- **Journal**: Research Policy, Vol. 30, No. 1, pp. 99-119
- **URL**: https://doi.org/10.1016/S0048-7333(99)00100-6
- **Policy change examined**: Bayh-Dole Act
- **Research question**: What drove the growth in university patenting — Bayh-Dole or other factors?
- **Methodology**: Case study of UC, Stanford, and Columbia patent portfolios
- **Key finding**: Bayh-Dole was only one of several important factors; had little effect on research content.
- **Relevance**: HIGH
- **Verification**: Confirmed on ScienceDirect

### Azoulay, Graff Zivin, Li & Sampat (2019)
- **Title**: "Public R&D Investments and Private-sector Patenting: Evidence from NIH Funding Rules"
- **Journal**: Review of Economic Studies, Vol. 86, No. 1, pp. 117-152
- **URL**: https://doi.org/10.1093/restud/rdy034
- **Policy change examined**: Federally funded research and university patenting (Bayh-Dole mechanism)
- **Research question**: How does public R&D funding affect private-sector patenting?
- **Methodology**: Exploits NIH peer review rigidities for exogenous variation
- **Key finding**: A $10 million boost in NIH funding leads to 2.7 additional patents. 10% of NIH grants generate a patent directly; 30% generate articles cited by patents.
- **Relevance**: HIGH
- **Verification**: Confirmed on Oxford Academic

### Lach & Schankerman (2008)
- **Title**: "Incentives and Invention in Universities"
- **Journal**: RAND Journal of Economics, Vol. 39, No. 2, pp. 403-433
- **URL**: https://doi.org/10.1111/j.0741-6261.2008.00020.x
- **Policy change examined**: Bayh-Dole royalty-sharing mechanisms
- **Research question**: Do financial incentives affect university invention?
- **Methodology**: Cross-university variation in royalty sharing
- **Key finding**: Stronger royalty incentives generate more licensing income; effect is larger in private universities.
- **Relevance**: HIGH
- **Verification**: Confirmed on Wiley

**Papers discarded during research:**
- Sampat, Mowery & Ziedonis (2003) — Published in Intl J. of Industrial Organization, not approved
- Shane (2004) — Published in J. of Business Venturing, not approved
- Astebro et al. (2019) — Published in ILR Review, not approved

---

## Federal Circuit Created (1982)

### Hall & Ziedonis (2001)
- **Title**: "The Patent Paradox Revisited: An Empirical Study of Patenting in the U.S. Semiconductor Industry, 1979-1995"
- **Journal**: RAND Journal of Economics, Vol. 32, No. 1, pp. 101-128
- **URL**: https://doi.org/10.2307/2696400
- **Policy change examined**: Federal Circuit creation
- **Research question**: Why did patenting surge in semiconductors despite weak patent effectiveness?
- **Methodology**: Panel data analysis of semiconductor firms 1979-1995
- **Key finding**: Stronger patent rights from CAFC spawned "patent portfolio races" among capital-intensive firms but also facilitated entry by design firms.
- **Relevance**: HIGH
- **Verification**: Confirmed on JSTOR/RAND

### Atkinson, Marco & Turner (2009)
- **Title**: "The Economics of a Centralized Judiciary: Uniformity, Forum Shopping, and the Federal Circuit"
- **Journal**: Journal of Law & Economics, Vol. 52, No. 3, pp. 411-443
- **URL**: https://doi.org/10.1086/597561
- **Policy change examined**: Federal Circuit creation
- **Research question**: Did the CAFC reduce nonuniformity and forum shopping?
- **Methodology**: Econometric analysis of pre- vs. post-CAFC patent validity rates across circuits
- **Key finding**: Pre-CAFC era had significant nonuniformity and forum shopping; CAFC substantially reduced both.
- **Relevance**: HIGH
- **Verification**: Confirmed on U. Chicago Press

### Galasso & Schankerman (2018)
- **Title**: "Patent Rights, Innovation, and Firm Exit"
- **Journal**: RAND Journal of Economics, Vol. 49, No. 1, pp. 64-86
- **URL**: https://doi.org/10.1111/1756-2171.12219
- **Policy change examined**: Federal Circuit patent invalidation
- **Research question**: How does patent invalidation affect patent holders?
- **Methodology**: Random judge assignment at Federal Circuit
- **Key finding**: Invalidation causes 50% reduction in subsequent patenting by patent holders; significantly increases exit probability for small firms.
- **Relevance**: HIGH
- **Verification**: Confirmed on Wiley

**Papers discarded during research:**
- Henry & Turner (2006) — Published in J. of Legal Studies, not approved
- Lanjouw & Lerner (2001) — J. Law & Econ but studies preliminary injunctions broadly, not CAFC creation

---

## Hatch-Waxman Act (1984)

### Scott Morton (1999)
- **Title**: "Entry Decisions in the Generic Pharmaceutical Industry"
- **Journal**: RAND Journal of Economics, Vol. 30, No. 3, pp. 421-440
- **URL**: https://doi.org/10.2307/2556056
- **Policy change examined**: Hatch-Waxman ANDA pathway
- **Research question**: What determines generic drug entry decisions post-Hatch-Waxman?
- **Methodology**: Analysis of all generic approvals 1984-1994
- **Key finding**: Prior experience with drug/therapy class reduces ANDA costs and increases entry probability; firms specialize.
- **Relevance**: HIGH
- **Verification**: Confirmed on JSTOR/RAND

### Reiffen & Ward (2005)
- **Title**: "Generic Drug Industry Dynamics"
- **Journal**: Review of Economics and Statistics, Vol. 87, No. 1, pp. 37-49
- **URL**: https://doi.org/10.1162/0034653053327694
- **Policy change examined**: Post-Hatch-Waxman generic drug market
- **Research question**: How do generic prices and entry evolve after patent expiration?
- **Methodology**: Structural estimation of generic drug markets
- **Key finding**: Generic prices fall with competitors but remain above marginal cost until 8+ entrants.
- **Relevance**: HIGH
- **Verification**: Confirmed on MIT Press

### Branstetter, Chatterjee & Higgins (2016)
- **Title**: "Regulation and Welfare: Evidence from Paragraph IV Generic Entry in the Pharmaceutical Industry"
- **Journal**: RAND Journal of Economics, Vol. 47, No. 4, pp. 857-890
- **URL**: https://doi.org/10.1111/1756-2171.12157
- **Policy change examined**: Hatch-Waxman Paragraph IV challenges
- **Research question**: What are the welfare effects of accelerated generic entry via Paragraph IV?
- **Methodology**: Structural estimation of hypertension drug markets 1997-2008
- **Key finding**: Paragraph IV challenges increase generic entry, lower prices, increase consumer welfare; settlements can reverse gains.
- **Relevance**: HIGH
- **Verification**: Confirmed on Wiley

### Ellison & Ellison (2011)
- **Title**: "Strategic Entry Deterrence and the Behavior of Pharmaceutical Incumbents Prior to Patent Expiration"
- **Journal**: American Economic Journal: Microeconomics, Vol. 3, No. 1, pp. 1-36
- **URL**: https://doi.org/10.1257/mic.3.1.1
- **Policy change examined**: Hatch-Waxman generic competition framework
- **Research question**: Do incumbents engage in strategic entry deterrence before patent expiration?
- **Methodology**: Analysis of advertising behavior before generic entry
- **Key finding**: Nonmonotonic investment in market size consistent with strategic entry deterrence in intermediate-sized markets.
- **Relevance**: HIGH
- **Verification**: Confirmed on AEA website

### Grabowski & Vernon (1992)
- **Title**: "Brand Loyalty, Entry, and Price Competition in Pharmaceuticals after the 1984 Drug Act"
- **Journal**: Journal of Law & Economics, Vol. 35, No. 2, pp. 331-350
- **URL**: https://doi.org/10.1086/467257
- **Policy change examined**: Hatch-Waxman Act directly
- **Research question**: How did the Act affect brand-generic competition?
- **Methodology**: Analysis of market dynamics post-1984
- **Key finding**: Generic competition intensified significantly; major brands lost over half their market share within first year after patent expiration.
- **Relevance**: HIGH
- **Verification**: Confirmed on U. Chicago Press

---

## TRIPS Agreement (1994)

### Chaudhuri, Goldberg & Jia (2006)
- **Title**: "Estimating the Effects of Global Patent Protection in Pharmaceuticals: A Case Study of Quinolones in India"
- **Journal**: American Economic Review, Vol. 96, No. 5, pp. 1477-1514
- **URL**: https://doi.org/10.1257/aer.96.5.1477
- **Policy change examined**: TRIPS pharmaceutical patent requirements
- **Research question**: What are the welfare effects of TRIPS on developing countries?
- **Methodology**: Structural demand estimation using Indian fluoroquinolones market
- **Key finding**: Withdrawal of domestic products would cause substantial welfare losses, even with price regulation.
- **Relevance**: HIGH
- **Verification**: Confirmed on AEA website

### Duggan, Garthwaite & Goyal (2016)
- **Title**: "The Market Impacts of Pharmaceutical Product Patents in Developing Countries: Evidence from India"
- **Journal**: American Economic Review, Vol. 106, No. 1, pp. 99-135
- **URL**: https://doi.org/10.1257/aer.20141301
- **Policy change examined**: India's 2005 TRIPS implementation
- **Research question**: How did TRIPS-mandated patents affect Indian drug markets?
- **Methodology**: Difference-in-differences using variation across molecules
- **Key finding**: Patented molecules had only 3-6% price increases; little impact on quantities or number of firms.
- **Relevance**: HIGH
- **Verification**: Confirmed on AEA website

### Kyle & McGahan (2012)
- **Title**: "Investments in Pharmaceuticals Before and After TRIPS"
- **Journal**: Review of Economics and Statistics, Vol. 94, No. 4, pp. 1157-1172
- **URL**: https://doi.org/10.1162/REST_a_00214
- **Policy change examined**: TRIPS
- **Research question**: Did TRIPS increase pharmaceutical R&D for developing-country diseases?
- **Methodology**: Cross-country panel on patent laws and disease-specific R&D
- **Key finding**: Patents in wealthy countries increase R&D, but developing-country patent laws did not increase R&D for diseases prevalent there.
- **Relevance**: HIGH
- **Verification**: Confirmed on MIT Press

### Qian (2007)
- **Title**: "Do National Patent Laws Stimulate Domestic Innovation in a Global Patenting Environment?"
- **Journal**: Review of Economics and Statistics, Vol. 89, No. 3, pp. 436-453
- **URL**: https://doi.org/10.1162/rest.89.3.436
- **Policy change examined**: TRIPS-era pharmaceutical patent laws (26 countries, 1978-2002)
- **Research question**: Does patent protection stimulate domestic pharmaceutical innovation?
- **Methodology**: Cross-country DiD analysis
- **Key finding**: National patent protection alone does not stimulate innovation; development, education, and economic freedom matter more. Optimal IPR level exists.
- **Relevance**: HIGH
- **Verification**: Confirmed on MIT Press

### Bilir (2014)
- **Title**: "Patent Laws, Product Life-Cycle Lengths, and Multinational Activity"
- **Journal**: American Economic Review, Vol. 104, No. 7, pp. 1979-2013
- **URL**: https://doi.org/10.1257/aer.104.7.1979
- **Policy change examined**: TRIPS-era patent reforms
- **Research question**: How do patent laws affect multinational activity across sectors?
- **Methodology**: Panel data on US multinationals exploiting TRIPS variation
- **Key finding**: Strong patents attract multinationals only in long-life-cycle sectors.
- **Relevance**: HIGH
- **Verification**: Confirmed on AEA website

### Chattopadhyay & Bercovitz (2020)
- **Title**: "When One Door Closes, Another Door Opens... For Some: Evidence from the Post-TRIPS Indian Pharmaceutical Industry"
- **Journal**: Strategic Management Journal, Vol. 41, No. 6, pp. 988-1022
- **URL**: https://doi.org/10.1002/smj.3140
- **Policy change examined**: India's TRIPS implementation
- **Research question**: How did Indian pharma firms respond to TRIPS?
- **Methodology**: Firm-level panel analysis
- **Key finding**: Firms' knowledge bases dictated their ability to pivot after TRIPS ended legal reverse engineering.
- **Relevance**: HIGH
- **Verification**: Confirmed on Wiley/SMJ

**Papers discarded during research:**
- Javorcik (2004) — European Economic Review, not approved
- Kanwar & Evenson (2003) — Oxford Economic Papers, not approved
- Maskus & Penubarti (1995) — J. Intl Economics, not approved
- Branstetter et al. (2011) — J. Intl Economics, not approved

---

## eBay v. MercExchange (2006)

### Farrell & Shapiro (2008)
- **Title**: "How Strong Are Weak Patents?"
- **Journal**: American Economic Review, Vol. 98, No. 4, pp. 1347-1369
- **URL**: https://doi.org/10.1257/aer.98.4.1347
- **Policy change examined**: Patent holdup (core concern of eBay)
- **Research question**: How do probabilistic patents affect welfare when licensed without full validity determination?
- **Methodology**: Theoretical model with welfare analysis
- **Key finding**: Weak patents extract high royalties when downstream users compete; examining validity prior to licensing is socially beneficial.
- **Relevance**: HIGH
- **Verification**: Confirmed on AEA website

### Appel, Farre-Mensa & Simintzi (2019)
- **Title**: "Patent Trolls and Startup Employment"
- **Journal**: Journal of Financial Economics, Vol. 133, No. 3, pp. 708-725
- **URL**: https://doi.org/10.1016/j.jfineco.2019.01.003
- **Policy change examined**: NPE/patent troll litigation (post-eBay)
- **Research question**: How does patent troll litigation affect startup employment?
- **Methodology**: Staggered adoption of anti-troll laws across 32 states
- **Key finding**: Anti-troll laws increase high-tech startup employment by 4.4%.
- **Relevance**: HIGH
- **Verification**: Confirmed on ScienceDirect

### Mezzanotti & Simcoe (2019)
- **Title**: "Patent Policy and American Innovation after eBay: An Empirical Examination"
- **Journal**: Research Policy, Vol. 48, No. 5, pp. 1271-1281
- **URL**: https://doi.org/10.1016/j.respol.2019.01.004
- **Policy change examined**: eBay and subsequent patent policy changes
- **Research question**: Did weakening patent enforcement harm American innovation?
- **Methodology**: Time-series analysis of patenting, R&D, VC, productivity
- **Key finding**: No evidence that post-eBay reforms harmed innovation.
- **Relevance**: HIGH
- **Verification**: Confirmed on ScienceDirect

**Papers discarded during research:**
- Bessen & Meurer (2014) — Cornell Law Review, not approved
- Lemley & Shapiro (2007) — Texas Law Review, not approved
- Chien (2012) — Stanford Tech Law Review, not approved

---

## America Invents Act (2011)

### Helmers & Love (2023)
- **Title**: "Patent Validity and Litigation: Evidence from US Inter Partes Review"
- **Journal**: Journal of Law & Economics, Vol. 66, No. 1, pp. 53-81
- **URL**: https://doi.org/10.1086/721911
- **Policy change examined**: AIA's inter partes review
- **Research question**: How does IPR affect parallel patent litigation?
- **Methodology**: Analysis of IPR filings and concurrent court proceedings
- **Key finding**: IPR filing and PTAB institution decisions have large positive effects on settlement of concurrent litigation.
- **Relevance**: HIGH
- **Verification**: Confirmed on U. Chicago Press

### Martinelli & Mazzei (2025)
- **Title**: "Death Squad or Quality Improvement? The Impact of Introducing Post-Grant Review on U.S. Patent Legal Quality"
- **Journal**: Research Policy, Vol. 54, No. 5, Article 105205
- **URL**: https://doi.org/10.1016/j.respol.2025.105205
- **Policy change examined**: AIA's post-grant review
- **Research question**: Did post-grant review improve patent quality or just invalidate good patents?
- **Methodology**: Difference-in-differences
- **Key finding**: AIA's review induced narrower claims, tighter examination, fewer challenges, saving $62-148M annually.
- **Relevance**: HIGH
- **Verification**: Confirmed on ScienceDirect

---

## American Inventors Protection Act (1999)

### Beyhaghi, Khashabi & Mohammadi (2023)
- **Title**: "Pre-grant Patent Disclosure and Analyst Forecast Accuracy"
- **Journal**: Management Science, Vol. 69, No. 5, pp. 3140-3155
- **URL**: https://doi.org/10.1287/mnsc.2022.4420
- **Policy change examined**: AIPA's 18-month publication requirement
- **Research question**: Does mandatory patent disclosure improve capital market information?
- **Methodology**: DiD using AIPA as policy shock
- **Key finding**: Pre-grant disclosure significantly improves analyst forecast accuracy, especially for R&D-intensive firms.
- **Relevance**: HIGH
- **Verification**: Confirmed on INFORMS

---

## Alice Corp. v. CLS Bank (2014)
No new papers found in the 23 approved journals that specifically study Alice empirically. The Alice literature remains in working papers (Feng & Williams on SSRN) and non-approved journals (J. of Economics & Management Strategy, Information Systems Research).

## KSR v. Teleflex (2007)
No new papers beyond Schankerman & Schuett (2022 REStud) already cited.

## TC Heartland v. Kraft Foods (2017)
No new papers in approved journals.

**Papers discarded during research:**
- Feng & Williams "Abstract Patents" — SSRN working paper only
- Frumkin et al. (2024) — J. Econ & Management Strategy, not approved
- Helmers & Love (2024) — Intl Rev. of Law & Econ, not approved
- Law, Qiu & Wang (2020) — Harvard Business Law Review, not approved
